Press Releases and Events
EVENTS
Past Events
Event | June 5, 2025 — 12:50 PM ET
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
WEBCAST
Event | May 8, 2025 — 4:30 PM ET
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8
Event | February 27, 2025 — 4:30 PM ET
Crinetics to Report Fourth Quarter and Full Year 2024 Financial Results
Event | January 14, 2025 — 7:30 AM ET
Crinetics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Event | January 10, 2025 — 8:30 AM ET
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia
Event | November 12, 2024 — 4:30 PM ET
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12
PRESENTATION
Event | September 4, 2024 — 5:35 PM ET
Crinetics Pharmaceuticals to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Event | August 8, 2024 — 4:30 PM ET
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8
Transforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
